Adaptive Biotechnologies Insider Sold Shares Worth $879,088, According to a Recent SEC Filing

MT newswire2026/10/22 08:59

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:59 AM EDT, 10/22/2026 (MT Newswires) -- Julie Rubinstein, President and Chief Operating Officer, on October 19, 2026, sold 35,643 shares in Adaptive Biotechnologies (ADPT) for $879,088. Following the Form 4 filing with the SEC, Rubinstein has control over a total of 377,802 common shares of the company, with 377,802 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1478320/000178066426000043/xslF345X05/form4.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Adaptive Biotechnologies Insider Sold Shares Worth $879,088, According to a Recent SEC Filing

You may also like

Crypto prices